SecBot SecBot
SECBOTREPLAY Home › Report › RDY

RDY · Dr

DR REDDYS LABORATORIES LTD · 6-K filed Apr 16, 2026 at 09:38 ET

At the news

NEUTRALIMPACT 2/10

6-K filed Apr 16, 2026 at 09:38 ET

Dr. Reddy's Laboratories announced that its Board of Directors will consider recommending a final dividend for the fiscal year 2025-26. This is a routine disclosure ahead of an upcoming board meeting and contains no financial results or material changes to operations.

  • Company: Dr. Reddy's Laboratories Ltd. (RDY)
  • Filing Type: Form 6-K (foreign private issuer report)
  • Event: Board meeting to consider final dividend for FY 2025-26
  • Date of Filing: April 16, 2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access